These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 16731673)

  • 1. No way back for quinolones in the treatment of gonorrhoea.
    Goold PC; Bignell CJ
    Sex Transm Infect; 2006 Jun; 82(3):225-6. PubMed ID: 16731673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2002.
    Commun Dis Intell Q Rep; 2003; 27(4):488-91. PubMed ID: 15508502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of quinolone-resistant Neisseria gonorrhoeae in Pakistan.
    Jabeen K; Khan E; Hasan R
    Int J STD AIDS; 2006 Jan; 17(1):30-3. PubMed ID: 16409676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing rates of quinolone-resistant Neisseria gonorrhoeae in Paris, France.
    Farhi D; Gerhardt P; Falissard B; Poupet H; Poyart C; Dupin N
    J Eur Acad Dermatol Venereol; 2007 Jul; 21(6):818-21. PubMed ID: 17567314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neisseria gonorrhoeae and emerging resistance to extended spectrum cephalosporins.
    Tapsall JW
    Curr Opin Infect Dis; 2009 Feb; 22(1):87-91. PubMed ID: 19532086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on the management of gonorrhea in adults in the United States.
    Newman LM; Moran JS; Workowski KA
    Clin Infect Dis; 2007 Apr; 44 Suppl 3():S84-101. PubMed ID: 17342672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Increased Neisseria gonorrhoeae quinolone resistance in Amsterdam].
    Peerbooms PG; Spaargaren J; Fennema JS; Cairo I; Coutinho RA
    Ned Tijdschr Geneeskd; 2001 Sep; 145(39):1899-900. PubMed ID: 11605315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic resistance in gonorrhoea with special reference to rosoxacin in the treatment of a multi-resistant case.
    Mahendran R; Jayakuru GN
    Ceylon Med J; 1981 Jun; 26(2):94-8. PubMed ID: 6821032
    [No Abstract]   [Full Text] [Related]  

  • 9. Gonorrhea: Data on antibiotic resistance and accompanying infections at the University Hospital Dresden over a 10-year time period.
    Abraham S; Poehlmann C; Spornraft-Ragaller P
    J Dtsch Dermatol Ges; 2013 Mar; 11(3):241-9. PubMed ID: 23194411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global resistance of Neisseria gonorrhoeae: when theory becomes reality.
    Lewis DA
    Curr Opin Infect Dis; 2014 Feb; 27(1):62-7. PubMed ID: 24275696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An insight into the drug resistance profile & mechanism of drug resistance in Neisseria gonorrhoeae.
    Patel AL; Chaudhry U; Sachdev D; Sachdeva PN; Bala M; Saluja D
    Indian J Med Res; 2011 Oct; 134(4):419-31. PubMed ID: 22089602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First Neisseria gonorrhoeae strain with resistance to cefixime causing gonorrhoea treatment failure in Austria, 2011.
    Unemo M; Golparian D; Stary A; Eigentler A
    Euro Surveill; 2011 Oct; 16(43):. PubMed ID: 22085601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delaying the widespread emergence of cephalosporin-resistant gonorrhoea: what is the best target?
    Tuddenham S; Ghanem KG
    Sex Transm Infect; 2015 Jun; 91(4):232-3. PubMed ID: 25990778
    [No Abstract]   [Full Text] [Related]  

  • 14. Implications of current recommendations for third-generation cephalosporin use in the WHO Western Pacific Region following the emergence of multiresistant gonococci.
    Tapsall JW
    Sex Transm Infect; 2009 Aug; 85(4):256-8. PubMed ID: 19261600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gonorrhoea treatment combined with population-level general cephalosporin and quinolone consumption may select for Neisseria gonorrhoeae antimicrobial resistance at the levels of NG-MAST genogroup: An ecological study in Europe.
    Kenyon C; Laumen J; Van Dijck C; De Baetselier I; Abdelatti S; Manoharan-Basil SS; Unemo M
    J Glob Antimicrob Resist; 2020 Dec; 23():377-384. PubMed ID: 33207228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonococcal resistance: evolving from penicillin, tetracycline to the quinolones in South Africa -- implications for treatment guidelines.
    De Jongh M; Dangor Y; Adam A; Hoosen AA
    Int J STD AIDS; 2007 Oct; 18(10):697-9. PubMed ID: 17945048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of and associated risk factors for fluoroquinolone-resistant Neisseria gonorrhoeae in California, 2000-2003.
    Bauer HM; Mark KE; Samuel M; Wang SA; Weismuller P; Moore D; Gunn RA; Peter C; Vannier A; DeAugustine N; Klausner JD; Knapp JS; Bolan G
    Clin Infect Dis; 2005 Sep; 41(6):795-803. PubMed ID: 16107976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Core groups, antimicrobial resistance and rebound in gonorrhoea in North America.
    Chan CH; McCabe CJ; Fisman DN
    Sex Transm Infect; 2012 Apr; 88(3):200-4. PubMed ID: 22169277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An audit of pharyngeal gonorrhoea treatment in a public sexual health clinic in Adelaide, South Australia.
    Hustig A; Bell C; Waddell R
    Int J STD AIDS; 2013 May; 24(5):399-400. PubMed ID: 23970709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of quinolone resistance in Neisseria gonorrhoeae in coastal Kenya.
    Duncan S; Thiong'o AN; Macharia M; Wamuyu L; Mwarumba S; Mvera B; Smith AD; Morpeth S; Graham SM; Sanders EJ
    Sex Transm Infect; 2011 Apr; 87(3):231. PubMed ID: 21307154
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.